GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
2022-03-07 $22.75 $24.44 $22.75 $23.53 1 458 300
2022-03-04 $24.30 $25.29 $23.02 $23.28 1 572 400
2022-03-03 $25.00 $25.50 $22.96 $24.42 2 971 300
2022-03-02 $25.00 $25.23 $22.25 $24.55 6 303 300
2022-03-01 $30.45 $31.46 $29.34 $29.46 1 497 900
2022-02-28 $30.50 $31.10 $29.95 $30.34 894 600
2022-02-25 $29.28 $30.63 $28.28 $30.63 784 400
2022-02-24 $26.90 $29.58 $26.47 $29.43 1 444 200
2022-02-23 $30.26 $30.31 $28.63 $28.64 863 100
2022-02-22 $29.28 $30.78 $29.26 $29.83 682 700
2022-02-18 $30.38 $31.38 $29.88 $30.07 788 100
2022-02-17 $31.19 $31.57 $30.15 $30.40 672 000
2022-02-16 $31.30 $32.11 $30.72 $31.49 772 600
2022-02-15 $31.08 $31.79 $30.84 $31.59 1 406 500
2022-02-14 $29.82 $30.67 $29.40 $30.25 717 100
2022-02-11 $29.97 $31.24 $29.29 $29.80 835 400
2022-02-10 $29.11 $31.32 $28.68 $30.01 1 227 600
2022-02-09 $27.58 $29.87 $27.58 $29.72 1 189 700
2022-02-08 $27.64 $27.98 $26.80 $27.34 698 100
2022-02-07 $27.90 $29.25 $27.62 $27.82 950 400
2022-02-04 $27.10 $27.87 $26.95 $27.79 802 100
2022-02-03 $26.64 $28.11 $26.31 $27.16 1 094 800
2022-02-02 $27.63 $27.75 $26.66 $27.15 855 500
2022-02-01 $27.30 $28.11 $26.31 $27.65 1 421 400
2022-01-31 $25.20 $26.92 $24.93 $26.89 1 887 200
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT